BMI vs ROP: Which Is the Better Buy in 2026?
Last updated November 2026
Short answer
ROP is the larger of the two ($46.70B market cap): the incumbent the market prices for continued execution (19.19x forward earnings, beta 0.66). BMI is the smaller challenger ($4.52B), actually pricier on forward earnings (31.24x): more room to run, but more to prove. If you believe BMI earns its premium (31.24x forward earnings, so the market expects more from it), BMI fits. If you believe in paying less for profit, ROP fits at 19.19x.
BMI vs ROP: the tie-breaker metrics
Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | BMI | ROP | What it tells you |
|---|---|---|---|
| Market cap | $4.52B | $46.70B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 31.24 | 19.19 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Trailing P/E | 35.98 | 18.66 | Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price. |
| Beta | 0.62 | 0.66 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 58% of range | 82% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 6.83 | 2.44 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Reading it: ROP is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.
Before you buy: how BMI and ROP affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. BMI and ROP share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined BMI and ROP exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does Badger Meter (BMI) do?
Badger Meter designs and sells water meters, flow-measurement instruments, and the radio and software layer (ORION and GALAXY radios, BEACON and OneNetwork software, and the broader BlueEdge portfolio) that turns municipal water systems into connected networks. Its core customers are North American water utilities upgrading from manual reads to automated meter reading (AMR) and advanced metering infrastructure (AMI), where cellular AMI is the gateway to leak detection, usage analytics, and recurring, high-margin SaaS revenue that compounds on top of the hardware installed base.
What does Roper Technologies (ROP) do?
Roper Technologies has spent the past decade reinventing itself from an industrial tools and equipment maker into a diversified holding company whose center of gravity is vertical-market software. It operates through three segments: Application Software (businesses like Deltek for government contractors, Vertafore in insurance, Aderant for law firms, Frontline in K-12 education, and Clinisys in diagnostics), Network Software (network-effect platforms such as DAT in freight and iPipeline in insurance), and Technology Enabled Products (Neptune water meters, Verathon and CIVCO in medical devices). More than half of total revenue is now recurring, coming from SaaS subscriptions, maintenance and transaction fees, and application plus network software together generate roughly three-quarters of revenue.
BMI vs ROP: how do they differ?
Both fit overlapping themes, but they are not interchangeable. Here is what each one depends on.
- BMI drivers: Cellular AMI installed base; Recurring software and SaaS attach.
- ROP drivers: Acquisition-driven compounding; Recurring, high-margin software mix.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: Near-term results are exposed to the timing of large utility AMI projects and to weaker short-cycle order rates, which pushed Q1 2026 EPS well below consensus and left revenue down year over year in Q1 and Q2; Q3 revenue was only flat and slightly below estimates. For ROP, sentiment is a visible risk: within the past year ROP fell to about $306 before rebounding to around $471 by November 2026, which shows how quickly the market can reprice a software compounder when growth or AI disruption worries rise and fade.
BMI or ROP: which should you pick?
If the story you believe is BMI's (Cellular AMI installed base), BMI is the more direct way to own it; if it is ROP's (Acquisition-driven compounding), ROP is. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the BMI and ROP guides.
BMI vs ROP: the full fundamentals
BMI. At about $155 per share on November 20, 2026, Badger Meter trades near 36 times trailing earnings and 31 times forward estimates, a richer multiple than in October after a 14% three-month rebound. Consensus expects 2026 EPS of about $4.47 (down about 7%) before rising about 12% to roughly $4.99 in 2027, so the price assumes growth returns next year. The eight analysts in Yahoo's consensus carry a mean target near $166 and a buy rating.
ROP. Roper trades near 19x both trailing and forward earnings and about 17x EV/EBITDA as of November 20, 2026, up from about 16x in October as the shares rallied, but still below the low-20s trailing multiple of early 2026 and its longer-run median. Part of the low trailing figure comes from an unusually large Q2 2026 GAAP profit, so the forward multiple on about $24.57 of 2027 consensus EPS is the cleaner read. Fourteen analysts carry a mean target near $469, roughly where the stock now trades.
Headline figures (approximate, November 2026): BMI shows revenue (ttm) ~$881M (Q3 2026 ~flat YoY), q3 2026 revenue / eps ~$236M / $1.24 (vs $1.22 est.), net income (ttm) ~$127M (~14% net margin), margins (gross / operating) ~42% / ~19%; ROP shows revenue (ttm) ~$8.4 billion (up ~7.6% YoY in Q3), q3 2026 revenue ~$2.17 billion, q3 2026 eps vs estimate $5.89 vs ~$5.79, gross / operating margin ~70% / ~28%.
The bottom line: BMI vs ROP
BMI and ROP are related but distinct: same themes, different businesses and risks. Neither wins in the abstract, and whichever you pick is worth sizing so one theme does not take over your portfolio. Walnut can show your combined BMI and ROP exposure against your real portfolio. It is not an investment adviser.
Wondering how BMI or ROP fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Your questions about Badger Meter
Ask Walnut's AI anything about BMI and see how it fits what you own.
FAQ
What is the difference between BMI and ROP?
+
Badger Meter designs and sells water meters, flow-measurement instruments, and the radio and software layer (ORION and GALAXY radios, BEACON and OneNetwork software, and the broader BlueEdge portfolio) that turns municipal water systems into connected networks. Roper Technologies has spent the past decade reinventing itself from an industrial tools and equipment maker into a diversified holding company whose center of gravity is vertical-market software. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is BMI or ROP the better stock?
+
Neither is universally better. ROP is the larger incumbent; BMI is the smaller challenger and looks pricier on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, BMI or ROP?
+
On forward P/E (as of November 2026), BMI trades at 31.24x and ROP at 19.19x, so ROP is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both BMI and ROP?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of BMI vs ROP?
+
BMI: Near-term results are exposed to the timing of large utility AMI projects and to weaker short-cycle order rates, which pushed Q1 2026 EPS well below consensus and left revenue down year over year in Q1 and Q2; Q3 revenue was only flat and slightly below estimates. After a roughly 14% rebound over three months, the stock carries a premium valuation (about 36 times trailing and 31 times forward earnings), so growth disappointment in 2027 can drive more multiple compression. Competition is intense from larger and well-capitalized rivals including Xylem (Sensus), Roper (Neptune), Mueller, and Itron, which can pressure pricing and share. Supply-chain costs, tariffs, and component availability can squeeze gross margins, and integration risk accompanies acquisitions like UDlive and 37South, the latter in a new country for the company. Utility budgets and municipal funding cycles add cyclicality to an otherwise steady end market. ROP: Sentiment is a visible risk: within the past year ROP fell to about $306 before rebounding to around $471 by November 2026, which shows how quickly the market can reprice a software compounder when growth or AI disruption worries rise and fade. The model depends on continually acquiring good companies at sensible prices, and rising multiples for premium software assets can weigh on returns over time. Aggressive M&A has also lifted debt to about $9.7 billion against roughly $311 million of cash (down from ~$11.3 billion in mid-2026) and left goodwill and intangibles as a large share of the balance sheet, creating impairment risk if acquired businesses underperform. The jump in Q2 2026 GAAP earnings flatters trailing ratios, so headline P/E and margin overstate the run-rate. AI could disrupt the switching costs and stickiness that protect its software niches. Finally, as a decentralized holding company spanning dozens of businesses, execution and integration risk is spread across many units and is harder for outsiders to monitor.
Related comparisons
Browse all stock comparisons.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell BMI or ROP; figures are approximate and dated (as of November 2026). Verify current data before investing.